z-logo
open-access-imgOpen Access
FCGBP Is a Promising Prognostic Biomarker and Correlates with Immunotherapy Efficacy in Oral Squamous Cell Carcinoma
Author(s) -
Ting Shen,
Jianying Zhang,
Yali Wang,
Binjie Liu
Publication year - 2022
Publication title -
journal of immunology research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.315
H-Index - 83
eISSN - 2314-8861
pISSN - 2314-7156
DOI - 10.1155/2022/8443392
Subject(s) - kegg , immune system , immunotherapy , proportional hazards model , downregulation and upregulation , cancer research , biomarker , cell , biology , basal cell , oncology , survival analysis , medicine , immunology , gene , gene expression , transcriptome , biochemistry , genetics

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom